Exiris Exiris
  • About Us
    • Company Profile
    • Management Team
    • Team
    • Board of Directors
    • Scientific Advisors
    • Publications & Patents
  • Technologies
    • Antibody ID
    • Drug Conjugate
    • Cancer Stem Cell
  • Drug Discovery Pipeline
  • Services
    • Platform Technologies
    • Biomarker Discovery
    • Human Skin Equivalents
    • Drug Development Services
  • News
  • Contacts
    • Job Opportunities
Exiris Exiris
  • About Us
    • Company Profile
    • Management Team
    • Team
    • Board of Directors
    • Scientific Advisors
    • Publications & Patents
  • Technologies
    • Antibody ID
    • Drug Conjugate
    • Cancer Stem Cell
  • Drug Discovery Pipeline
  • Services
    • Platform Technologies
    • Biomarker Discovery
    • Human Skin Equivalents
    • Drug Development Services
  • News
  • Contacts
    • Job Opportunities
Oct 07

Exiris presents a “High Complexity-High Efficiency Human Antibody Phage Display Library” at the Festival of Biologics (FOB) 2019, Basel 15-17 October 2019

  • 7th October 2019
  • News

Exiris Human Antibody Phage Display Library for identification of high affinity monoclonal antibodies, without need of further affinity maturation, will be presented at the FOB 2019 https://www.terrapinn.com/conference/festival-of-biologics/index.stm. Details on several projects expedited by the use of the library will be shown.

  • Facebook
  • Twitter
  • Google+
  • LinkedIn
  • E-Mail

Comments are closed.

Latest News

  • Interview with Paola Gallinari on “Osservatorio medico-scientifico”
  • Exiris @ RaiNews24
  • Exiris presents a “High Complexity-High Efficiency Human Antibody Phage Display Library” at the Festival of Biologics (FOB) 2019, Basel 15-17 October 2019
  • Exiris receives European Union research grant for the ETN MAGICBULLET RELOADED project
  • New data presented at the 35th European Peptide Symposium, 35EPS, Dublin 26th-31st August 2018
  • New data presented at the Peptides and Conjugates for Tumor Targeting, Therapy and Diagnosis, Riminipeptide2018 Congress
  • Exiris is awarded a grant from Regione Lazio LIFE 2020
  • Exiris files patent application on novel cancer therapeutic antibodies
  • New data presented at the 7th Annual World ADC Berlin 2017
  • Exiris @ Presa Diretta
© 2016 Exiris Srl · P.IVA 10897561006